Voyager Therapeutics, Inc. Common Stock — Quarterly Financial Statements (NASDAQ:VYGR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Market Capitalization 241.0924 M
Employee 172
Founded 2013
CEO N/A
Website www.voyagertherapeutics.com
Headquarter Delaware, United States
FIGI BBG005ZSY233
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

241.09 M Market capitalization

Price to earnings ratio

-2.16

Price to sales ratio

8.69

Dividends per share

—

Dividend yield %

—

News

Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates

Alzheimer's Clinical Trial Results, Sadly Running True To Form

J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline - Johnson & Johnson (NYSE:JNJ)

Voyager Therapeutics stock price target lowered to $25 at H.C. Wainwright

Voyager Therapeutics at Stifel Conference: Neurotherapeutic Innovations

Voyager Therapeutics stock price target raised to $12 by Leerink Partners

Voyager Therapeutics Inc earnings beat by $0.05, revenue topped estimates

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates

Transition Bio, Voyager partner on ALS drug discovery

Moderna (MRNA) Reports Q3 Loss, Tops Revenue Estimates

Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock?

What's Going On With Voyager Therapeutics Stock Monday? - Voyager Therapeutics (NASDAQ:VYGR)